Found 835 matching trials
Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. NA This randomized, double-blind, placebo-controlled trial will evaluate the i...
Show More Location
Center of New Medical Technologies
Learn More & Join Trial
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma PHASE2 The study is being conducted to evaluate the efficacy and safety of convers...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
Study of Gamma Interfereon in Metastatic Colorectal Carcinoma PHASE2 The purpose of this study is to evalute the response and toxicity of metast...
Show More Learn More & Join Trial
Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer N/A This single arm study aims to evaluate the rate of conversion therapy in pa...
Show More Location
Cho Ray hospital- 201 B Nguyen Chi Thanh, District 5
Learn More & Join Trial
Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer PHASE2 Patients with locally advanced or metastatic pancreatic adenocarcinoma not ...
Show More Location
Instituto do Câncer do Estado de São Paulo
Learn More & Join Trial
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX PHASE3 The aim of this adaptive Phase 3 trial is to show a statistically significa...
Show More Location
Compassionate Cancer Care Medical Group, Inc
Learn More & Join Trial
Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis PHASE3 This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Show More Location
Istituto Giannina Gaslini
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients PHASE2 The object of this trial is to test whether ivonescimab is superior to stan...
Show More Location
CHU Amiens Picardie
Learn More & Join Trial